Join us via WebEx for a dual presentation from Dr. Paul Armistead, discussing "Targeting leukemia minor histocompatibility antigens for AML immunotherapy," and Dr. Natalie Grover, discussing "Early Phase CAR-T Cell Trials at UNC."   Paul Armistead, MD, PhD Chronology BS Chemistry: University of North Carolina, 1995; PhD Chemistry: University of North Carolina, 1997-2000; MD: University … Read more